Shares of DocGo Inc. (NASDAQ:DCGO – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six research firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $4.89.
A number of analysts have weighed in on DCGO shares. Needham & Company LLC reduced their price objective on shares of DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a research note on Friday, February 28th. Stifel Nicolaus cut their price target on shares of DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a report on Friday, February 28th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of DocGo from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $5.00 to $2.85 in a report on Friday, February 28th.
Check Out Our Latest Stock Analysis on DocGo
Institutional Trading of DocGo
DocGo Price Performance
Shares of NASDAQ:DCGO opened at $2.77 on Tuesday. The company has a market capitalization of $282.49 million, a PE ratio of 9.89, a PEG ratio of 14.16 and a beta of 1.08. The business has a fifty day moving average price of $4.15 and a 200-day moving average price of $3.94. DocGo has a 1-year low of $2.63 and a 1-year high of $5.68.
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Read More
- Five stocks we like better than DocGo
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Insider Trading – What You Need to Know
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.